Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing v3.6.3, indicating a software version update rather than changes to the clinical study details.
    Difference
    0.1%
    Check dated 2026-07-25T16:56:11.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's version.
    Difference
    0.1%
    Check dated 2026-07-04T13:34:20.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a small update to the site template or underlying code. The core study information and its presentation remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-27T07:47:01.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page adds a recruitment status note and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the heading formatting for Intervention/Treatment as well as the revision label to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:56:24.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a newer revision of the record. This appears to be a maintenance update to the page rather than a substantive change to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:36:24.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Adds a new page revision tag v3.5.4 and removes v3.5.3, signaling a rebuild/update of the page's version rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T11:38:24.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.